fbpx

FORGOT YOUR DETAILS?

Learn More About BellBrook's Drug Discovery Services

Drug Discovery Services Offered By BellBrook Labs

BellBrook’s drug discovery services specialize in small molecule modulators for enzyme drug targets. We have conducted assay development & lead discovery for over 15 years. Our experts work diligently with varieties of customers in early-stage drug discovery programs. From assay development to lead discovery, we provide quality data to accelerate programs.

Lead Discovery Services Graphic

Assay Development Services

Scientists Performing Assay Development Services
  • Target Protein Sourcing/Production - If the target protein is available from the customer or a vendor, we will test it for purity and functional activity; if not, we will produce it using the most efficient and cost-effective expression and purification strategy.
  • Assay Optimization with Target Protein - We will determine the optimal buffer composition, enzyme concentration, and reaction time & optimize detection reagents to produce maximal signal under initial velocity conditions.
  • Assay Validation - Depending on customer needs, validation could include dose responses with control inhibitors, determination of kinetic parameters, pilot screens with targeted libraries, or interference screens.

Example Assay Optimization with Human cGAS

BellBrook scientists performed a detection of purified, full-length human cGAS with the Transcreener cGAMP FP Assay. Linear response is shown from polarization data converted to cGAMP using a standard curve.

Lead Discovery Services

Scientists Performing Lead Drug Discovery Services
  • Inhibitor Screening - To identify or confirm activity with the target.
  • Inhibitor Potency Profiling - Dose-response with target and/or related proteins. Fast IC50 results.
  • Inhibitor Selectivity Profiling
  • Residence Time Measurements - Determination of koff using 'jump dilution' enzymatic assay method.
  • Mechanism of Action Studies - Kinetic analysis to define the mode of inhibition.
  • Triaging Non-Stoichiometric Inhibitors - Run assays under different conditions such as varying detergent and enzyme concentrations.
  • Evaluate Compound-Target Binding - Run thermal shift assays to confirm compound-target engagement via shifts in melting temperature.

Example Inhibitor Screening & Profiling With Human cGAS

BellBrook scientists performed an inhibitor screening & inhibitor potency profiling of cGAS using the Transcreener cGAMP cGAS Assay.

Inhibitor Screening

Pilot cGAMP Assay Pilot Screen

Shown above is a screen of 1600 compounds. cGAS was used at 10 nM, compounds were at 10 μM. Z = 0.62, Z’ = 0.7 illustrate a robust screening assay. Hits were determined to be anything outside three standard deviations from the mean. 

Inhibitor Potency Profiling

IC50 of cGAS Inhibitor

Confirmation of a screening hit using the Transcreener cGAMP cGAS Assay in the FP format. Follow-up assays to triage screening hits can be used to selective bonafide inhibitors for advancement into medicinal chemistry/SAR.

Choose Your Target

Please inquire if you do not see your target. We may have experience with that target or a similar one within an enzyme family. If you want to learn more about a target, click on the target listed below. 

Example Target Families
Protein Kinases
Lipid Kinases
Carbohydrate Kinases
ATPases
Acetyltransferases
HDACs
GTPases, GAPs, GEFs
Phosphodiesterases
Helicases
Nucleotidases
Ligases/Synthetases
Glycosyltransferases

Talk To A Scientist

Let's talk science. We'd like to learn more about your target, your goals, and how we can accelerate your program.

We'll Do The Work

Send us your compounds. We'll use the proven Transcreener Assay to measure enzymatic activity. Drug discovery services will be performed in a timely manner at our lab in Madison, WI. 

Quickly Provide a Report & Support

We'll provide a full report including the raw data and results of the experiments. We can keep things as simple or complex as you like. 

Download Our App Note

Transcreener® HTS Assay Overview For Drug Discovery Services

BellBrook’s Transcreener® HTS assay platform is ideally suited for the detailed biochemical and kinetic analyses required for hit-to-lead programs. Transcreener® is an extensively validated HTS technology platform that produces robust FP, TR-FRET and FI signals for nucleotides produced by enzymes; e.g. ADP for kinases. It has been used to screen tens of millions of wells over the last 10 years in pharma and biotech labs looking to accelerate small molecule drug discovery for several therapeutic areas.

Transcreener Overview for Drug Discovery Services

Because they use direct immunodetection of nucleotides, Transcreener® assays can provide more reliable results than alternative methods that rely on more complicated schemes involving coupling enzymes. In addition, the ability to run Transcreener® assays in continuous mode enables analysis of inhibitor binding kinetics such as residence time, which is increasingly recognized as an important factor for drug efficacy. For our services, additional assay methods will be employed as needed to meet customer requirements.

Why Choose BellBrook Labs to Accelerate Your Program?

Leveraging BellBrook’s services expertise will save you time and money. Your project will be handled by the same BellBrook scientists who developed the Transcreener assays and have optimized them for more than 100 different enzyme targets, including kinases, ATPase, GTPases, glycosyltransferases, ligases/synthetases, and phosphodiesterases. We will tailor our efforts to meet your specific needs. For example, minimizing consumption of limited reagents or enabling simultaneous screening for inhibitors and activators. And we will work fast. If your target enzyme is in good shape, we can generally complete the services within two to four weeks.

Advantage of BellBrook's Drug Discovery Services

Contact Us to Learn More About Drug Discovery Services

Please fill out the form below. We will respond quickly to get the conversation moving and learn how we can help. We keep things discrete, confidential, and professional.

TOP